New combination treatment for early Alzheimer's or memory loss
Part of Brain & nervous system, Mental health clinical trials.
This trial tests a new combination treatment (DAOIB and an antioxidant) for people with early Alzheimer's or mild cognitive impairment. It aims to see if the treatment can help slow or improve memory and thinking problems.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with Alzheimer's disease or mild cognitive impairment
- Your memory test (MMSE) score is between 10 and 26
- Your dementia rating (CDR) is 0.5 (very mild) or 1 (mild)
- You do not have a history of stroke or other major blood flow problems in the brain
- You do not have Parkinson's disease, epilepsy, dementia with psychosis, major depression, or a serious physical illness
- You have no severe vision or hearing loss, and no substance abuse issues
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new oral drug called 2-HOBA (a natural compound found in curry) in people with early-stage Alzheimer's. The drug may help protect brain cells and possibly slow memory decline. Participants will take the drug daily for a period, and researchers will monitor changes in cognition and biomarkers.
This Phase 2 trial tests an oral medicine (EX039) to see if it can help people with mild Alzheimer’s disease. It focuses on slowing or improving thinking and memory problems over time.
This trial studies a non-medication (non-drug) program to improve memory and daily thinking in people with mild cognitive impairment or mild Alzheimer’s disease. It may help by supporting brain function and monitoring symptoms over time.
This study tests a sequence of treatments to see if they can help people with Alzheimer's disease or mild cognitive impairment. It aims to slow down memory decline and improve daily function.
This study enrolls people with no memory impairment, mild memory problems, or mild Alzheimer’s dementia to test how brain scans and cognitive tests relate to Alzheimer’s disease. It may help by contributing to better early diagnosis and by letting you see whether you fit into the study’s imaging and blood-test pathway.
This trial tests whether acupuncture can improve symptoms in people with Alzheimer’s disease. You may qualify if you have memory and thinking changes consistent with Alzheimer’s and meet imaging and brain-scan score requirements.
Hear when a new Mild Cognitive Impairment trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.